Effects of Diet Interventions on Monocytes in Metabolic Syndrome
1 other identifier
interventional
20
1 country
1
Brief Summary
Subjects with hypertriglyceridemia and metabolic syndrome are being recruited and receive diet interventions with either a high-saturated fat diet or a low-fat high protein diet for 4 days (days 1-4) and a breakfast on day 5. Blood samples are collected on day 1 and day 5 to examine lipid levels and circulating monocyte phenotypes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 9, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2020
CompletedJuly 8, 2020
July 1, 2020
4 years
July 9, 2018
July 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Effects of diet interventions on monocyte phenotypes
Monocyte phenotypes
2016 to 2020
Study Arms (2)
high-saturated fat diet
ACTIVE COMPARATORDiet high in saturated fat (\~50% calorie from fat, \~25% from saturated fat)
low-fat diet
ACTIVE COMPARATORDiet with low fat (\~25% calorie from fat)
Interventions
The study includes 2 types of diets, i.e., high-saturated fat diet and low-fat high-protein diet, which are provided to each participant in a randomized crossover design.
Eligibility Criteria
You may qualify if:
- Obese women and men with metabolic syndrome (MS)
- Fasting triglyceride (TG) equal to or greater than 150 mg/dl
You may not qualify if:
- \<21 years of age
- Perimenopausal, pregnant or breastfeeding women
- Current smokers
- Obvious inflammation or other acute illnesses
- Obesity due to endocrinologic disorders including polycystic ovary syndrome
- Partial lipodystrophy
- Diabetes requiring insulin or \>1 oral medication
- Fasting TG ≥650 mg/dl
- A history of pancreatitis
- Myocardial infarction within the past 3 years
- Any hospitalization within the past 2 months
- Takes steroids.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Center for Prevention of cardiometabolic disease
Houston, Texas, 77030, United States
Related Publications (1)
Lian Z, Perrard XD, Antony AK, Peng X, Xu L, Ni J, Zhang B, O'Brien V, Saeed A, Jia X, Hussain A, Yu B, Simon SI, Sacks FM, Hoogeveen RC, Ballantyne CM, Wu H. Dietary Effects on Monocyte Phenotypes in Subjects With Hypertriglyceridemia and Metabolic Syndrome. JACC Basic Transl Sci. 2023 Apr 26;8(5):460-475. doi: 10.1016/j.jacbts.2023.02.011. eCollection 2023 May.
PMID: 37325398DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
HUAIZHU WU, MD
Baylor College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 9, 2018
First Posted
July 19, 2018
Study Start
April 1, 2016
Primary Completion
March 31, 2020
Study Completion
March 31, 2020
Last Updated
July 8, 2020
Record last verified: 2020-07